FOXO Technologies Inc. (FOXO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.000099 (9,900.00%)
At close: Apr 27, 2026

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Healthcare
16.09M4.02M---
Healthcare Growth
300.26%----
Life Science Services
252.50K----
Labs
13.92K32.64K145.29K--
Labs Growth
-57.34%-77.53%---
Corporate and Other
15.09K----
FOXO Labs
---483.00K85.00K
FOXO Labs Growth
---468.24%269.57%
FOXO Life
---28.00K35.00K
FOXO Life Growth
----20.00%-12.50%
Total
16.37M4.05M145.29K511.00K120.00K
Total Growth
303.98%2688.61%-71.57%325.83%90.48%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
16.37M4.05M145.29K511.00K120.00K
United States Growth
303.98%2688.61%-71.57%325.83%90.48%
Total
16.37M4.05M145.29K511.00K120.00K
Total Growth
303.98%2688.61%-71.57%325.83%90.48%
Source: S&P Global Market Intelligence.